Neuropeptide Y Promotes Sleep and Reduces Stress Hormones in Young Men
Intranasal neuropeptide Y reduced cortisol and ACTH while promoting sleep in healthy young men, demonstrating anxiolytic and sleep-promoting effects that oppose the stress hormone CRH.
Quick Facts
What This Study Found
Intranasal NPY promoted sleep and reduced ACTH and cortisol in healthy young men, demonstrating CRH-opposing anxiolytic and sedative effects with potential therapeutic applications for depression and insomnia.
Key Numbers
How They Did This
Randomized study in healthy young men. NPY administered intranasally. Sleep architecture (polysomnography), plasma ACTH, and cortisol measured over the study night compared to placebo.
Why This Research Matters
Depression and insomnia involve CRH overactivity. If NPY can oppose CRH effects through a simple nasal spray, it could offer a fundamentally different approach to treating these common conditions without the side effects of current medications.
The Bigger Picture
The CRH-NPY balance may be key to stress resilience. People with depression and PTSD may have too much CRH relative to NPY. Restoring this balance with exogenous NPY represents a novel therapeutic concept.
What This Study Doesn't Tell Us
Small study in healthy men only. Acute effects may not predict chronic therapeutic use. Intranasal peptide delivery is variable. Effects in patients with actual depression/insomnia not tested.
Questions This Raises
- ?Would intranasal NPY help patients with depression-related insomnia?
- ?Does chronic NPY administration maintain these effects?
- ?Is the cortisol reduction clinically significant for stress-related disorders?
Trust & Context
- Key Stat:
- Sleep promoted, cortisol reduced Intranasal NPY simultaneously improved sleep and suppressed stress hormones, opposing CRH's effects on both systems
- Evidence Grade:
- Moderate evidence from a controlled human study with objective sleep and hormonal measurements, though limited by small sample and acute design.
- Study Age:
- Published in 2000. NPY-based approaches for anxiety, depression, and PTSD continue to be explored, with intranasal delivery as a potential route.
- Original Title:
- Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men.
- Published In:
- Neuropharmacology, 39(8), 1474-81 (2000)
- Authors:
- Antonijevic, I A, Murck, H, Bohlhalter, S, Frieboes, R M, Holsboer, F, Steiger, A
- Database ID:
- RPEP-00574
Evidence Hierarchy
Frequently Asked Questions
Could a nasal spray help with stress and sleep?
This study shows neuropeptide Y delivered by nasal spray promoted sleep and reduced stress hormones in healthy men. If it works in patients with depression or insomnia, it could offer a novel, non-addictive treatment.
How does NPY relate to stress?
NPY naturally opposes the stress hormone CRH. In people with depression and PTSD, the CRH-NPY balance is disrupted. Boosting NPY with a nasal spray could help restore this balance and reduce stress-related symptoms.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00574APA
Antonijevic, I A; Murck, H; Bohlhalter, S; Frieboes, R M; Holsboer, F; Steiger, A. (2000). Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men.. Neuropharmacology, 39(8), 1474-81.
MLA
Antonijevic, I A, et al. "Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men.." Neuropharmacology, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Neuropeptide Y promotes sleep and inhibits ACTH and cortisol..." RPEP-00574. Retrieved from https://rethinkpeptides.com/research/antonijevic-2000-neuropeptide-y-promotes-sleep
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.